卢瑟福血管外科学参考文献下载978-7-5659-0410-3

参考文献

上卷

第1章

1.EylerJM.ThechangingassessmentsofJohnSnow‘sandWilliamFarr‘scholerastudies.SozPraventivmed.

2001;46:225-232.

2.HaynesRB,SackettDL,GrayJM,etal.Transferringevidencefromresearchintopractice:1.Theroleofclinicalcare

researchevidenceinclinicaldecisions.ACPJClub.1996;125:A14-A16.

3.DawberTR,KannelWB.TheFraminghamstudy.Anepidemiologicalapproachtocoronaryheartdisease.Circulation.

1966;34:553-555.

4.KannelWB,CastelliWP,McNamaraPM.Cigarettesmokingandriskofcoronaryheartdisease.Epidemiologiccluesto

pathogenesis.TheFraminghamStudy.NatlCancerInstMonogr.1968;28:9-20.

5.FreedmanB.Equipoiseandtheethicsofclinicalresearch.NEnglJMed.1987;317:141-145.

6.SmithGC,PellJP.Parachuteusetopreventdeathandmajortraumarelatedtogravitationalchallenge:systematicreviewof

randomisedcontrolledtrials.BMJ.2003;327:1459-1461.

7.SmithML,GlassGV.Meta-analysisofpsychotherapyoutcomestudies.AmPsychol.1977;32:752-760.

8.StroupDF,BerlinJA,MortonSC,etal.Meta-analysisofobservationalstudiesinepidemiology:aproposalforreporting.

Meta-analysisOfObservationalStudiesinEpidemiology(MOOSE)group.JAMA.2000;283:2008-2012.

9.JonesDR.Meta-analysisofobservationalepidemiologicalstudies:Areview.JRSocMed.1992;85:165-168.

10.BeggCB,MazumdarM.Operatingcharacteristicsofarankcorrelationtestforpublicationbias.Biometrics.

1994;50:1088-1101.

11.EggerM,DaveySmithG,SchneiderM,etal.Biasinmeta-analysisdetectedbyasimple,graphicaltest.BMJ.

1997;315:629-634.

12.NguyenLL,ConteMS,MenardMT,etal.Infrainguinalveinbypassgraftrevision:factorsaffectinglong-termoutcome.J

VascSurg.2004;40:916-923.

13.ConteMS,BandykDF,ClowesAW,etal.ResultsofPREVENTIII:amulticenter,randomizedtrialofedifoligideforthe

preventionofveingraftfailureinlowerextremitybypasssurgery.JVascSurg.2006;43:742-751,discussion751.

14.McDermottMM,MehtaS,LiuK,etal.Legsymptoms,theankle-brachialindex,andwalkingabilityinpatientswith

peripheralarterialdisease.JGenInternMed.1999;14:173-181.

15.AllisonMA,HiattWR,HirschAT,etal.Ahighankle-brachialindexisassociatedwithincreasedcardiovasculardisease

morbidityandlowerqualityoflife.JAmCollCardiol.2008;51:1292-1298.

16.GuyattGH,SullivanMJ,ThompsonPJ,etal.The6-minutewalk:anewmeasureofexercisecapacityinpatientswith

chronicheartfailure.CanMedAssocJ.1985;132:919-923.

17.MontgomeryPS,GardnerAW.Theclinicalutilityofasix-minutewalktestinperipheralarterialocclusivediseasepatients.

JAmGeriatrSoc.1998;46:706-711.

18.LeFaucheurA,AbrahamP,JaquinandiV,etal.Measurementofwalkingdistanceandspeedinpatientswithperipheral

arterialdisease:anovelmethodusingaglobalpositioningsystem.Circulation.2008;117:897-904.

19.WareJEJr,SherbourneCD.TheMOS36-itemshort-formhealthsurvey(SF-36).I.Conceptualframeworkanditem

selection.MedCare.1992;30:473-483.

20.RabinR,deCharroF.EQ-5D:AmeasureofhealthstatusfromtheEuroQolGroup.AnnMed.2001;33:337-343.

21.RegensteinerJG,SteinerJF,PanzerRJ,etal.Evaluationofwalkingimpairmentbyquestionnaireinpatientswithperipheral

arterialdisease.JVascMedBiol.1990;2:142-150.

22.MorganMB,CrayfordT,MurrinB,etal.DevelopingtheVascularQualityofLifeQuestionnaire:anewdisease-specific

qualityoflifemeasureforuseinlowerlimbischemia.JVascSurg.2001;33:679-687.

23.NguyenLL,MonetaGL,ConteMS,etal.Prospectivemulticenterstudyofqualityoflifebeforeandafterlowerextremity

veinbypassin1404patientswithcriticallimbischemia.JVascSurg.2006;44:977-983.

第2章

1.CarlsonBM.HumanEmbryologyandDevelopmentalBiology.4thed.Philadelphia:Elsevier;2009:116-119.

2.ZhanW,YatskievychTA,BakerRK,AntinPB.RegulationofHexgeneexpressionandinitialstagesofavianhepatogenesis

byBmpandFgfsignaling.DevBiol.2004;268:312-326.

3.LinFJ,TsaiM-J,TsaiSY.Arteryandveinformation:atugofwarbetweendifferentforces.EMBORep.2007;8:920-924.

4.Red-HorseK,CrawfordY,ShojaeiF,FerraraN.Endothelium-microenvironmentinteractionsinthedevelopingembryoand

intheadult.DevCell.2007;12:181-194.

5.CarlsonBM.HumanEmbryologyandDevelopmentalBiology.4thed.Philadelphia:Elsevier;2009:437-483.

6.KadirS.Regionalanatomyofthethoracicaorta.In:KadirS,ed.AtlasofNormalandVariantAngiographicAnatomy.

Philadelphia:WBSaunders;1991:19-54.

7.ArciniegasE,HakimiM,HertzlerJH,etal.Surgicalmanagementofcongenitalvascularrings.JThoracCardiovascSurg.

1979;77:721-727.

8.MahoneyEB,ManningJA.Congenitalabnormalitiesoftheaorticarch.Surgery.1964;55:1-14.

9.RichardsonJV,DotyDB,RossiNP,EhrenhaftJL.Operationforaorticarchanomalies.AnnThoracSurg.1981;31:426-432.

10.BinetJP,LongloisJ.Aorticarchanomaliesinchildrenandinfants.JThoracCardiovascSurg.1977;73:248-253.

11.LincolnJC,DeverallPB,StarkJ,etal.Vascularanomaliescompressingtheesophagusandtrachea.Thorax.

1969;24:295-306.

12.DaviesM,GuestPJ.Developmentalabnormalitiesofthegreatvesselsofthethoraxandtheirembryologicalbasis.BrJ

Radiol.2003;76:491-502.

13.JaffeRB.Completeinterruptionoftheaorticarch.2.Characteristicangiographicfeatureswithemphasisoncollateral

circulationtothedescendingaorta.Circulation.1976;53:161-168.

14.MerklinRJ,MichaelsNA.Thevariantrenalandsuprarenalbloodsupplywithdataoninferiorphrenic,ureteral,andgonadal

arteries:astatisticalanalysisbasedon185dissectionsandreviewoftheliterature.JIntCollSurg.1958;29:41-76.

15.RidleyJH.Thekidneyandureter.In:GraySW,SkandalakisJE,eds.EmbryologyforSurgeons.TheEmbryologicBasisfor

theTreatmentofCongenitalDefects.Philadelphia:WBSaunders;1972:443-552.

16.AnsonBJ,RichardsonGA,MinearWL.Variationsinthenumberandarrangementoftherenalvessels.Astudyoftheblood

supplyoffourhundredkidneys.JUrol.1936;36:211-219.

17.CarlsonBM.HumanEmbryologyandDevelopmentalBiology.4thed.Philadelphia:Elsevier;2009:230-233.

18.Rodriguez-NiedenfuhrM,BurtonGJ,DeuJ,SanudoJR.Developmentofthearterialpatternintheupperlimbofstaged

humanembryos:normaldevelopmentandanatomicvariations.JAnat.2001;199:407-417.

19.SeniorHD.Thedevelopmentofthearteriesofthehumanlowerextremity.AmJAnat.1919;25:55-95.

20.MayschakDT,FlyeWM.Treatmentofthepersistentsciaticartery.AnnSurg.1984;199:69-74.

21.McLellanGL,MorettinLB.Persistentsciaticartery:clinical,surgical,andangiographicaspects.ArchSurg.

1982;117:817-822.

22.BrantleySK,RigdonEE,RajuS.Persistentsciaticartery:embryology,pathology,andtreatment.JVascSurg.

1993;18:242-248.

23.GibsonMH,MillsJG,JohnsonGE,DownsAR.Poplitealentrapmentsyndrome.AnnSurg.1977;185:341-348.

24.CarlsonBM.HumanEmbryologyandDevelopmentalBiology.4thed.Philadelphia:Elsevier;2009:449-453.

25.LarsenWJ.HumanEmbryology.3rded.Philadelphia:ChurchillLivingstone;2001,pp209-217.

26.NandyK,BlairCBJr.Doublesuperiorvenaecavaewithcompletelypairedazygousveins.AnatRec.1965;151:161-172.

27.WinterFS.Persistentleftsuperiorvenacava:surveyofworldliteratureandreportofthirtyadditionalcases.Angiology.

1954;5:90-132.

28.BabaianRJ,JohnsonDE.Majorvenousanomaliescomplicatingretroperitonealsurgery.SouthMedJ.1979;72:1254-1258.

29.ChuangVP,MenaCE,HoskinsPA.Congenitalanomaliesoftheleftrenalvein:angiographicconsideration.BrJRadiol.

1974;47:214-218.

30.DardikH,LoopFD,CoxPA,KeshishianJM.―C-pattern‖inferiorvenacava.Embryogenesisandclinicalimplications.

JAMA.1967;200:248-249.

31.KolbenstvedtA,KolmannskogF,LienHH.Theanomalousinferiorvenacava—anotherstructurebetweentheaortaandthe

superiormesentericartery.BrJRadiol.1981;54:423.

32.BrenerBJ,DarlingRC,FrederickPL,LintonRR.Majorvenousanomaliescomplicatingabdominalaorticsurgery.Arch

Surg.1974;108:159-165.

33.MayoJ,GrayR,StLouisE,etal.Anomaliesoftheinferiorvenacava.AJRAmJRoentgenol.1983;140:339-345.

34.GiordanoJM,TroutHHIII:Anomaliesoftheinferiorvenacava.JVascSurg.1986;3:924-928.

第3章

1.RutherfordRB,ed.VascularSurgery.4thed.Philadelphia,PA:WBSaunders;1995.

2.SidawyA,SumpioB,DePalmaR,eds.TheBasicScienceofVascularDisease.Armonk,NY:Futura;1997.

3.AirdW.PhenotypicheterogeneityoftheendotheliumI.Structure,function,andmechanisms.CircRes.2007;100:158-173.

4.ClarkJ,GlagovS.Luminalsurfaceofdistendedarteries,eliminatingconfigurationalandtechnicalartefacts.BrJExp

Pathol.1976;57:129-135.

5.LevyB,TedguiA,eds.BiologyoftheArterialWall.Norwell,MA:KluwerAcademic;1999.

6.vandenBergB,VinkH,SpaanJ.Theendothelialglycocalyxprotectsagainstmyocardialedema.CircRes.

2003;92:592-594.

7.SmithM,LongD,DamianoE,etal.Near-wallmicro-PIVrevealsahydrodynamicallyrelevantendothelialsurfacelayerin

venulesinvivo.BiophysJ.2003;85:637-645.

8.MarchesiV.Theroleofpinocyticvesiclesinthetransportofmaterialsacrossthewallsofsmallbloodvessels.Invest

OphthalmolVisSci.1965;4:1111-1121.

9.RostgaardJ,QvortrupK.Electronmicroscopicdemonstrationsoffilamentousmolecularsieveplugsincapillaryfenestrae.

MicrovascRes.1997;53:1-13.

10.SimionescuM,SimionescuN,PaladeG.Morphometricdataontheendotheliumofbloodcapillaries.JCellBiol.

1974;60:128-152.

11.WisseE.Anelectronmicroscopicstudyofthefenestratedendothelialliningofratliversinusoids.JUltrastructureRes.

1970;31:125-150.

12.KramerR,BenschK,DavisonP,etal.Basallaminaformationbyculturedmicrovascularendothelialcells.JCellBiol.

1984;99:692-698.

13.WangC,ShuaibA.Criticalroleofmicrovasculaturebasallaminainischemicbraininjury.ProgNeurobiol.

2007;83:140-148.

14.Ts‘aoC,GlagovS.Basalendothelialattachment:tenacityatcytoplasmicdensezoneintherabbitaorta.LabInvest.

1970;23:510-516.

15.SchnittlerH,FrankeR,AkbayU,etal.Improvedinvitrorheologicalsystemforstudyingtheeffectoffluidshearstresson

culturedcells.AmJPhysiol.1993;265:C289-C298.

16.LaurentS,BoutouyrieP,LacolleyP.Structuralandgeneticbasesforarterialstiffness.Hypertension.2005;45:1050-1055.

17.WightT.Cellbiologyofarterialproteoglycans.Arteriosclerosis.1989;9:1-20.

18.MerwinJ,AndersonJ,KocherO,etal.Transforminggrowthfactor1modulatesextracellularmatrixorganizationand

cell-celljunctionalcomplexformationduringinvitroangiogenesis.JCellPhysiol.1990;142:117-128.

19.KocherO,MadriJ.ModulationofactinmRNAsinculturedcapillaryendothelialandaorticendothelialandsmoothmuscle

cellsbymatrixcomponentsandTGF-1.InVitro.1989;25:424-434.

20.GrandD,LelkesP,FukudaK,etal.Intracellularmechanismsinvolvedinbasementmembrane–inducedbloodvessel

differentiationinvitro.InVitroCellDevBiol.1991;27A:327-336.

21.MadriJ,PrattB.Endothelialcellmatrix-interactions:invitromodelsofangiogenesis.JHistochemCytochem.

1986;34:85-91.

22.IngberD,FolkmanJ.Mechanochemicalswitchingbetweengrowthanddifferentiationduringfibroblastgrowthfactor–

stimulatedangiogenesisinvitro:roleofextracellularmatrix.JCellBiol.1989;109:317-330.

23.MechamR,MaradrasJ,McDonaldJ,etal.Elastinproductionbyculturedcalfpulmonaryarteryendothelialcells.JCell

Physiol.1963;116:282-288.

24.DamianoV,TsonaA,KueichU,etal.Immunoelectronmicroscopicstudiesoncellssynthesizingelastin.ConnectTissue

Res.1981;8:185-188.

25.SimsF.Theinitiationofintimalthickeninginhumanarteries.Pathology.2000;32:171-175.

26.TadaS,TarbellJ.Fenestralpowersizeintheinternalelasticlaminaaffectstheflowdistributioninthearterywall.Ann

BiomedEng.2002;29:456-466.

27.ClarkJ,GlagovS.Structuralintegrationofthearterialwall.I:Relationshipsandattachmentsofmedialsmoothmuscle

cellsinnormallydistendedandhyperdistendedaortas.LabInvest.1979;40:587-602.

28.DavisE.Smoothmusclecelltoelasticlaminaconnectionsindevelopingmouseaorta.Roleinaorticmedialorganization.

LabInvest.1993;68:89-99.

29.BerryC,Sosa-MelgarejoJ,GreenwaldS.Therelationshipbetweenwalltension,lamellarthickness,andintercellular

junctionsinthefetalandadultaorta:itsrelevancetothepathologyofdissectinganeurysm.JPathol.1993;169:15-20.

30.JohnsonJ,JacksonC.AtheroscleroticplaqueruptureintheapolipoproteinEknockoutmouse.Atherosclerosis.

2001;154:399-406.

31.SimsF,GavinJ,KoelmeyerS,etal.Comparisonoftheendothelialsurfaceandthesubjacentelasticlaminaoftheanterior

descendingcoronaryarteriesatthelocationoftheatheromatouslesionswithinternalthoracicarteriesofthesamesubjects:

ascanningelectronmicroscopicstudy.Pathology.2002;34:433-441.

32.GuoZY,YanZQ,BaiL,etal.Flowshearstressaffectsmacromolecularaccumulationthroughmodulationofinternal

elasticlaminafenestrae.ClinBiomech(Bristol,Avon).2008;23(Suppl1):S104-S111.

33.PennM,SaidelG,ChisolmG.Relativesignificanceofendotheliumandinternalelasticlaminainregulatingtheentryof

macromoleculesintoarteriesinvivo.CircRes.1994;74:74-82.

34.AvolioA,JonesD,Tafazzoli-ShadpourM.Quantificationofalterationsinstructureandfunctionofelastininthearterial

media.Hypertension.1998;32:170-175.

35.DobrinP.Distributionoflamellardeformations:implicationsforpropertiesofthearterialmedia.Hypertension.

1999;33:806-810.

36.ThybergJ.Differentiatedpropertiesandproliferationofarterialsmoothmusclecellsinculture.IntRevCytol.

1996;169:183-265.

37.CaiW,KocsisE,WuX,etal.Remodelingofthevasculartunicamediaisessentialforthedevelopmentofcollateral

vesselsinthecanineheart.MolCellBiochem.2004;264:201-210.

38.ClarkJ,GlagovS.Transmuralorganizationofthearterialmedia:thelamellarunitrevisited.Arteriosclerosis.1985;5:19-34.

39.WolinskyH,GlacovS.Alamellarunitofaorticmedialstructureandfunctioninmammals.CircRes.1967;20:99-111.

40.GoreR,BohlenH.Pressureregulationinthemicrocirculation.FedProcs.1975;34:2031-2037.

41.GrowB.Circulatorycorrelates:vascularimpedance,resistance,andcapacitance.In:BohrDF,SomlyoAP,SparksHV,eds.

TheCardiovascularSystem,VolII.VascularSmoothMuscle.Baltimore,MD:AmericanPhysiologicalSociety(Williams

&Wilkins);1980:353-408.

42.HughesA,ThomS,MartinG,etal.Sizeandsite-dependentheterogeneityofhumanvascularresponsesinvitro.J

Hypertens.1988;6:S173-S175.

43.AarsH.Diameterandelasticityoftheascendingaortaduringinfusionofnoradrenaline.ActaPhysiolScand.

1971;83:133-138.

44.OwenM.Phentolamine-resistantneurogenicconstrictionoccursinsmallarteriesathigherfrequencies.AmJPhysiol.

1985;249:H404-H414.

45.MulvanyM,AalkjaerC.Structureandfunctionofsmallarteries.PhysiolRev.1990;70:922-946.

46.GriffithS,CroweJ,LincolnA,etal.Regionaldifferencesinthedensityofperivascularnervesandvaricosities,

noradrenalinecontentandresponsestonervestimulationintherabbitearartery.BloodVessels.1982;19:41-52.

47.CarlsonE,BurrowsM,JohnsonP.Electronmicroscopicstudiesofcatmesentericarterioles,astructure-functionanalysis.

MicrovascRes.1982;24:123-141.

48.BoutouyrieP,LacolleyP,GirerdX,etal.Sympatheticactivationdecreasesradialarterycomplianceinhumans.AmJ

Physiol.1994;267:H1368-H1376.

49.SumpioB,ed.HemodynamicForcesandVascularCellBiology.Austin,TX:RGLandes;1993.

50.ShimokawaH,YasutakeH,FujiiK,etal.Theimportanceofthehyperpolarizingmechanismincreasesasthevesselsize

decreasesinendothelium-dependentrelaxationsinratmesentericcirculation.JCardiovascPharmacol.1996;28:703-711.

51.ScotlandR,MadhaniM,ChauhanS,etal.Investigationofvascularresponsesinendothelialnitricoxide

synthase/cyclooxygenase-1double-knockoutmice.Circulation.2005;111:796-803.

52.RyanU,RubanyiG,eds.EndothelialRegulationofVascularTone.NewYork,NY:MarcelDekker;1992.

53.Colden-StanfieldM,SchillingW,RitchieA,etal.Bradykinin-inducedincreasesincytosoliccalciumandioniccurrentin

culturedbovineaorticendothelialcells.CircRes.1987;61:632-640.

54.RheeS,SuhP,RyuS,etal.Studiesofinositolphospholipid-specificphospholipaseC.Science.1989;244:546-550.

55.KatadaT,GilmanA,WatanabeY,etal.ProteinkinaseCphosphorylatestheinhibitoryguanine-nucleotide-binding

regulatorycomponentandapparentlysuppressesitsfunctioninhormonalinhibitionofadenylatecyclase.EurJBiochem.

1985;151:431-437.

56.BennetC,CrookeS.Purificationandcharacterizationofaphosphoinositide-specificphospholipaseCfromguineapig

uterus.JBiolChem.1987;262:13789-13797.

57.JakenS.Diacylglycerol:theroleofstimulatedproductioninactivationofproteinkinaseC.In:IyengarR,BirnbaumerL,

eds.G-Proteins.SanDiego,CA:AcademicPress;1990:163-178.

58.NishizukaY.ThemolecularheterogeneityofproteinkinaseCanditsimplicationsforcellularregulation.Nature.

1988;334:661-665.

59.PhillipsW,FujikiT,RossiM,etal.InfluenceofcalciumonthesubcellulardistributionofproteinkinaseCinhuman

neutrophils.JBiolChem.1989;264:8361-8365.

60.GertlerJ,AbbottW.Currentresearchreview:prothromboticandfibrinolyticfunctionofnormalandperturbedendothelium.

JSurgRes.1992;52:89-95.

61.LuscherT,VanhoutteP,eds.TheEndothelium:ModulatorofCardiovascularFunction.Boston,MA:CRCPress;1990.

62.VanhoutteP.Endotheliumandcontrolofvascularfunction.Stateoftheartlecture.Hypertension.1989;13:658-667.

63.Arandomizedtrialofaspirinandsulfinpyrazoneinthreatenedstroke.TheCanadianCooperativeStudyGroup.NEnglJ

Med.1978;299:53.

64.MoncadaS.Prostacyclinandarterialwallbiology.ArteriosclThombVascBiol.1982;2:193-207.

65.MacintyreD,PearsonJ,GordonJ.Localisationandstimulationofprostacyclinproductioninvascularcells.Nature.

1978;271:549-551.

66.VallanceP,WebbD,eds.VascularEndotheliuminHumanPhysiologyandPathophysiology.Amsterdam,Netherlands:

HarwoodAcademicPublishers;2000.

67.BestL,MartinT,RussellR,etal.ProstacyclinincreasescyclicAMPlevelsandadenylatecyclaseactivityinplatelets.

Nature.1977;267:850-851.

68.MoncadaS,GryglewskiR,BuntingS,etal.Anenzymeisolatedfromarteriestransformsprostaglandinendoperoxidesto

anunstablesubstancethatinhibitsplateletaggregation.Nature.1976;263:663-665.

69.GormanR,BuntingS,MillerO.Modulationofhumanplateletadenylatecyclasebyproxtacyclin(PGX).Prostaglandins.

1977;13:377-388.

70.RadomskiM,MoncadaS.Biologicroleofnitricoxideinplateletfunction.In:MoncadaS,HiggsEA,BerrazuetaS,eds.

ClinicalRelevanceofNitricOxideintheCardiovascularSystem.Madrid:EDICOMPLET;1991:45-56.

71.MoncadaS,HiggsA.Thel-arginine–nitricoxidepathway.NEnglJMed.1993;329:2002-2012.

72.SpieckerM,PendH,LiaoJ.Inhibitionofendothelialvascularcelladhesionmolecule-1expressionbynitricoxideinvolves

theinductionandnucleartranslocationofI-B.JBiolChem.1997;272:30969-30974.

73.TsaoP,WangB,BuitragoR,etal.Nitricoxideregulatesmonocytechemotacticprotein-1.Circulation.1997;96:934-940.

74.KatsuyamaK,ShichiriM,MarumoF,etal.NOinhibitscytokine-inducediNOSexpressionandNF-Bactivationby

interferingwithphosphorylationanddegradationofIB.ArteriosclerThrombVascBiol.1998;18:1796-1802.

75.KubesP,SuzukiM,GrangerD.Nitricoxide:anendogenousmodulatorofleukocyteadhesion.ProcNatlAcadSciUSA.

1991;88:4651-4655.

76.NakakiT,NakayamaM,KatoR.Inhibitionbynitricoxideandnitricoxide–producingvasodilatorsofDNAsynthesisin

vascularsmoothmusclecells.EurJPharmacol.1990;189:347-353.

77.SarkarR,MeinbergE,StanleyJ,etal.Nitricoxidereversiblyinhibitsthemigrationofculturedvascularsmoothmuscle

cells.CircRes.1996;78:225-230.

78.LeeJ,AdrieC,JacobH,etal.Chronicinhalationofnitricoxideinhibitsneointimalformationafterballoon-inducedarterial

injury.CircRes.1996;78:337-342.

79.NaruseK,SimizuK,MuramatsuM,etal.Long-terminhibitionofNOsynthesispromotesatherosclerosisin

hypercholesterolaemicrabbitthoracicaorta:PGH2doesnotcontributetoimpairedendothelium-dependentrelaxation.

ArteriosclerThrombVascBiol.1994;14:746-752.

80.IgnarroL.Haem-dependentactivationofguanylatecyclaseandcyclicGMPformationbyendogenousnitricoxide:a

uniquetransductionmechanismfortranscellularsignaling.PharmacolToxicol.1990;67:1-7.

81.HobbsA.Solubleguanylatecyclase:theforgottensibling.TrendsPharmacolSci.1997;18:484-490.

82.BolotinaV,NajibiS,PalacinoJ,etal.Nitricoxidedirectlyactivatescalcium-dependentpotassiumchannelsinvascular

smoothmuscle.Nature.1994;368:850-853.

83.JiaL,BonaventuraC,BonaventuraJ,etal.S-Nitrosohaemoglobin:adynamicactivityofbloodinvolvedinvascularcontrol.

Nature.1996;380:221-226.

84.BoulangerC,LuscherT.Releaseofendothelinfromtheporcineaorta.Inhibitionofendotheliumderivednitricoxide.J

ClinInvest.1990;85:587-590.

85.ReesD,PalmerR,SchulzR,etal.Characterizationofthreeinhibitorsofendothelialnitricoxidesynthaseinvitroandin

vivo.BrJPharmacol.1990;101:746-751.

86.HassidA,ArabshahiH,BourcierT,etal.NitricoxideselectivelyamplifiesFGF-2-inducedmitogenesisinprimaryaortic

smoothmusclecells.AmJPhysiol.1994;267:H1040-H1048.

87.FishJE,MarsdenPA.Endothelialnitricoxidesynthase:insightintocell-specificgeneregulationinthevascular

endothelium.CellMolLifeSci.2006;63:144-162.

88.BultH,BoeckxstaeinsG,PelckmansP,etal.Nitricoxideasaninhibitorynon-adrenergicnon-cholinergicneurotransmitter.

Nature.1990;345:346-347.

89.SchmidtK,WernerE,MayerB,etal.Tetrahydrobiopterin-dependentformationofendothelium-derivedrelaxingfactor

(nitricoxide)inaorticendothelialcells.BiochemJ.1992;281:297-300.

90.VallanceP,LeaoneA,CalverA,etal.Accumulationofanendogenousinhibitorofnitricoxidesynthesisinchronicrenal

failure.Lancet.1992;339:572-575.

91.BogerR,Bode-BogerS,BrandesR,etal.Dietaryl-argininereducestheprogressionofatherosclerosisincholesterol-fed

rabbits:comparisonwithlovastatin.Circulation.1997;96:1282-1290.

92.BusseR,MulschA,FlemingI,etal.Mechanismsofnitricoxidereleasefromthevascularendothelium.Circulation.

1993;87:V18-V25.

93.UematsoM,OharaY,NavasJ,etal.RegulationofendothelialcellnitricoxidesynthasemRNAexpressionbyshearstress.

AmJPhysiol.1995;269:C1371-C1378.

94.PapapetropoulousA,Garcia-CardenaG,MadriJ,etal.Nitricoxideproductioncontributestotheangiogenicpropertiesof

vascularendothelialgrowthfactorinhumanendothelialcells.JClinInvest.1997;100:3131-3139.

95.Rosenkranz-WeissP,SessaW,MilstienS,etal.Regulationofnitricoxidesynthesisbyproinflammatorycytokinesin

humanumbilicalveinendothelialcells.JClinInvest.1994;93:2236-2243.

96.LiaoJ,ShinW,LeeW,etal.Oxidizedlow-densitylipoproteinsdecreasetheexpressionofendothelialnitricoxidesynthase.

JBiolChem.1995;270:319-324.

97.AndersonH,RahmutulaD,GardnerD.Tumornecrosisfactor-alphainhibitsendothelialnitric-oxidesynthasegene

promoteractivityinbovineaorticendothelialcells.JBiolChem.2004;279:963-969.

98.McQuillanL,LeungG,MarsdenP,etal.HypoxiainhibitsexpressionofeNOSviatranscriptionalandposttranscriptional

mechanisms.AmJPhysiol.1994;267:H1921-H1927.

99.WilcoxJ,SubramanianR,SundellC,etal.Expressionofmultipleisoformsofnitricoxidesynthaseinnormaland

atheroscleroticvessels.ArteriosclerThrombVascBiol.1997;17:2479-2488.

100.SpagnoliLG,VillaschiS,NeriL,etal.Gapjunctionsinmyo-endothelialbridgesofrabbitcarotidarteries.Experientia.

1982;38:124-125.

101.MombouliJ,VanhoutteP.Endothelium-derivedhyperpolarizingfactor(s):updatingtheunknown.TrendsPharmacolSci.

1997;18:252-256.

102.WagnerO,ChristG,WojtaJ.Polarsecretionofendothelin-1byculturedendothelialcells.JBiolChem.

1992;267:16066-16068.

103.StewartD,LanglebenD,CernacekP.Endothelinreleaseisinhibitedbycocultureofendothelialcellswithcellsofvascular

media.AmJPhysiol.1990;259:H1928-H1932.

104.RensenS,DoevendansR,vanEysGJ.Regulationandcharacteristicsofvascularsmoothmusclecellphenotypicdiversity.

NethHeartJ.2007;15:100-108.

105.MombouliJ,BissiriouI,AgbotonD,etal.Bioassayofendothelium-derivedhyperpolarizingfactor.BiochemBiophysRes

Commun.1996;221:484-488.

106.TaylorS,SouthertonJ,WestonA,etal.Endothelium-dependenteffectsofacetylcholineinrataorta:acomparisonwith

sodiumnitroprussideandcromakalim.